Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05977751Not ApplicableRecruiting

Prospective Multi-Center Trial for FemBloc Permanent Birth Control

Role: lead

NCT03433911Not ApplicableCompleted

FemBloc® Permanent Contraception - Early Pivotal Trial

Role: lead

NCT04273594Not ApplicableActive Not Recruiting

FemBloc® Permanent Contraception - Confirmation Feasibility Trial

Role: lead

NCT04968847Not ApplicableCompleted

FemaSeed LOCAL Artificial Insemination Trial

Role: lead

NCT03067272Not ApplicableCompleted

Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception

Role: lead

NCT01053052Not ApplicableWithdrawn

Study of FemVue(TM) Sono Tubal Evaluation System Method Comparison to HSG

Role: lead

All 6 trials loaded